Skip to the answer

Etoposide Uses, Dosage, Side Effects and Interactions

Brand names
VePesid

VePesid was the first etoposide product the FDA approved, in November 1983. An FDA-approved generic with the same active ingredient is listed.

Toposar

Toposar is a generic etoposide sold under its own name, approved by the FDA in February 1995. The FDA now lists it as discontinued; generic etoposide is still listed.

Etopophos

Etopophos is a brand of etoposide that comes as an injection. An FDA-approved generic with the same active ingredient is listed.

Avopef

Avopef came 42 years after VePesid (February 2026) as an injection. The FDA rates no generic as a substitute for it.

Etoposide is a chemotherapy medicine (a topoisomerase inhibitor) used with other cancer treatments for small cell lung cancer and, in injection forms, for refractory testicular cancer.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 19, 2026 Where our facts come from

Quick links

Ask Anything About EtoposideType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Etoposide in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Etoposide is a decades-old chemotherapy standby, on the market since about 1983 with FDA-approved generics listed, that damages cancer cells’ DNA by interfering with an enzyme called topoisomerase II. It is given with other cancer drugs for small cell lung cancer and, in injection forms, for testicular cancer that has resisted earlier treatment. Most people notice nausea, tiredness, mouth sores or hair loss that grows back, and these are usually manageable. The one to watch is its boxed warning for severe bone marrow suppression (falling blood counts), which can lead to serious, even fatal, infection or bleeding, so call your cancer team right away about fever, chills, or unusual bruising or bleeding.

Key Takeaways From the HelloPharmacist Team

  • Expect treatment in cycles of a few days, by slow IV drip or capsules, repeated every 3 to 4 weeks once you recover.
  • Plan on a blood count before every cycle, since the next round waits if your white cells or platelets are too low.
  • Use effective birth control during and for months after treatment, since etoposide can harm an unborn baby, and this applies to men too.
  • Keep etoposide capsules in the refrigerator, and wear gloves when pressing them out of the blister pack.

How we write and review this content: our editorial policy

FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Etoposide.

Avopef can cause severe bone marrow suppression, which can lead to serious infection or bleeding. Bone marrow makes your blood cells, and when it is suppressed your body has fewer cells to fight infection and stop bleeding.

Avopef should not be given if your neutrophil count (a type of infection-fighting white blood cell) is below 500 cells/mm3 or your platelets are below 50,000/mm3. Your care team checks blood counts before each cycle and during and after treatment. Report fever, chills, unusual bruising or bleeding right away.

Read the full warning on DailyMed →

Etoposide by the Numbers

Strengths
4
across 2 forms
Makers and packagers
10
Earliest FDA record
1983
Rank by Medicaid prescriptions
#876 of 1,682 drugs
More prescriptions than 47% of the 1,682 drugs we measure
14,672 prescriptions, Q1–Q4 2025
Other forms and routes

Patient Information Guide for Etoposide

What It’s Used For

Etoposide is used with other cancer treatments for these conditions:

  • Small cell lung cancer: first-line treatment with Etoposide capsules, VePesid capsules and Etoposide Injection.
  • Small cell lung cancer, Etopophos: used with cisplatin.
  • Small cell lung cancer, Avopef: used with chemotherapy and immunotherapy in adults.
  • Refractory testicular cancer: Etoposide Injection, Etopophos and Avopef, in combination with other chemotherapy.

How It Works

Etoposide causes breaks in DNA by interacting with topoisomerase II, an enzyme cells need to copy DNA. It may also form free radicals. Cells stall mainly at the G2 stage of the cell cycle and then die.

Drug Class

Drug Class

  • Topoisomerase Inhibitor
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Topoisomerase Inhibitor

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Topoisomerase Inhibitors

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Etoposide in the FDA’s index.

From our Patient Information GuideEtoposide causes breaks in DNA by interacting with topoisomerase II, an enzyme cells need to copy DNA. It may also form free radicals. Cells stall mainly at the G2 stage of the cell cycle and then die. Read How Etoposide Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)

None listed for Etoposide in the FDA’s index.

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Podophyllotoxin derivatives

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Etoposide is given in cycles, usually repeated every 3 to 4 weeks after recovery from side effects. Your doctor adjusts the dose for other chemotherapy, past radiation or chemotherapy, and kidney function.

  • Capsules: taken by mouth. The oral dose is about twice the IV dose. Store them in the refrigerator.
  • Injection: given by slow IV infusion by a healthcare professional.

Follow your prescriber and the label.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Etoposide Injection

Testicular tumors that have not responded to treatment
Adults · Days 1 through 5 Dose 50 to 100 mg/m2/day
  • 50 to 100 mg/m2/day on days 1 through 5

Good to know

Courses repeated at 3- to 4-week intervals

Adults · Days 1, 3 and 5 Dose 100 mg/m2/day
  • 100 mg/m2/day on days 1, 3, and 5

Good to know

Courses repeated at 3- to 4-week intervals

Adults · Etopophos 100 mg/m2 · Days 1 through 5 Dose 50 to 100 mg/m2/day
  • 50 to 100 mg/m2 per day intravenously over 5 minutes to 3.5 hours on days 1 through 5 of each 21-day (or 28-day cycle)

Good to know

75% of dose if CLcr 15 to 50 mL/min

Etopophos is a brand name for this medicine. See Etopophos’s full dosing instructions on DailyMed →

CrCl means creatinine clearance, a measure of how well the kidneys work.

Adults · Etopophos 100 mg/m2 · Days 1 3 5 Dose 100 mg/m2
  • 100 mg/m2 intravenously over 5 minutes to 3.5 hours on days 1, 3, and 5 of each 21-day (or 28-day cycle)

Good to know

75% of dose if CLcr 15 to 50 mL/min

Etopophos is a brand name for this medicine. See Etopophos’s full dosing instructions on DailyMed →

CrCl means creatinine clearance, a measure of how well the kidneys work.

Small cell lung cancer
Adults · 4-day schedule Dose 35 mg/m2/day
  • 35 mg/m2/day for 4 days, in combination with other approved chemotherapeutic drugs

Good to know

Courses repeated at 3- to 4-week intervals

Adults · 5-day schedule Dose 50 mg/m2/day
  • 50 mg/m2/day for 5 days, in combination with other approved chemotherapeutic drugs

Good to know

Courses repeated at 3- to 4-week intervals

Adults · Etopophos 35 mg/m2 Dose 35 mg/m2/day
  • 35 mg/m2 per day intravenously over 5 minutes to 3.5 hours for 4 days

Good to know

75% of dose if CLcr 15 to 50 mL/min

Etopophos is a brand name for this medicine. See Etopophos’s full dosing instructions on DailyMed →

CrCl means creatinine clearance, a measure of how well the kidneys work.

Adults · Etopophos 50 mg/m2 Dose 50 mg/m2/day
  • 50 mg/m2 per day intravenously over 5 minutes to 3.5 hours for 5 days

Good to know

75% of dose if CLcr 15 to 50 mL/min

Etopophos is a brand name for this medicine. See Etopophos’s full dosing instructions on DailyMed →

CrCl means creatinine clearance, a measure of how well the kidneys work.

See the Full Dosing Instructions on DailyMed →

Avopef

Testicular cancer that has not responded to treatment
Adults · Days 1 to 5 Dose 50 to 100 mg/m2
  • 50 mg/m2 to 100 mg/m2 intravenously daily on Days 1 to 5

Good to know

Repeat cycles every 3 to 4 weeks

Adults · Days 1, 3 and 5 Dose 100 mg/m2 daily
  • 100 mg/m2 intravenously daily on Days 1, 3 and 5

Good to know

Repeat cycles every 3 to 4 weeks

Adults with kidney problems · Days 1 through 5 Dose 37 to 75 mg/m2
  • 37 mg/m2 to 75 mg/m2 Days 1 through 5

Good to know

Kidney adjustment for CLcr 15 to 50 mL/min; repeat cycles every 3 to 4 weeks

CrCl means creatinine clearance, a measure of how well the kidneys work.

Adults with kidney problems · Days 1, 3 and 5 Dose 75 mg/m2
  • 75 mg/m2 Days 1, 3 and 5

Good to know

Kidney adjustment for CLcr 15 to 50 mL/min; repeat cycles every 3 to 4 weeks

CrCl means creatinine clearance, a measure of how well the kidneys work.

Small cell lung cancer
Adults · Days 1 to 4 Dose 35 mg/m2 daily
  • 35 mg/m2 intravenously daily on Days 1 to 4

Good to know

Repeat cycles every 3 to 4 weeks

Adults · Days 1 to 5 Dose 50 mg/m2 daily
  • 50 mg/m2 intravenously daily on Days 1 to 5

Good to know

Repeat cycles every 3 to 4 weeks

Adults with kidney problems · Days 1 through 4 Dose 26 mg/m2
  • 26 mg/m2 Days 1 through 4

Good to know

Kidney adjustment for CLcr 15 to 50 mL/min; repeat cycles every 3 to 4 weeks

CrCl means creatinine clearance, a measure of how well the kidneys work.

Adults with kidney problems · Days 1 through 5 Dose 37 mg/m2
  • 37 mg/m2 Days 1 through 5

Good to know

Kidney adjustment for CLcr 15 to 50 mL/min; repeat cycles every 3 to 4 weeks

CrCl means creatinine clearance, a measure of how well the kidneys work.

See the Full Dosing Instructions on DailyMed →

Etoposide Taken by Mouth

Small cell lung cancer
For adults
Dose 50 mg
  • Two times the IV dose rounded to the nearest 50 mg (i.e., two times 35 mg/m2/day for 4 days to 50 mg/m2/day for 5 days)

Good to know

Courses repeated at 3- to 4-week intervals

IV means given into a vein (intravenous).

See the Full Dosing Instructions on DailyMed →

Side Effects

Common side effects include:

Common side effects

  • Low white blood cell counts (higher infection risk)
  • Low platelets and anemia
  • Nausea and vomiting
  • Loss of appetite
  • Diarrhea
  • Hair loss (reversible)
  • Mouth sores
  • Tiredness or weakness
  • Low white blood cells, platelets and red blood cells

When to get medical help

  • Fever, chills or other signs of infection, since blood counts can drop very low
  • Unusual bleeding or bruising
  • Signs of a severe allergic reaction during or after treatment: chills, fever, fast heartbeat, wheezing, trouble breathing, throat tightness, facial or tongue swelling, or dizziness
  • Pain, swelling or redness at the IV site, which can mean the drug leaked into the tissue
  • Severe skin reactions or blistering
  • Vision changes or seizures
  • Cough or breathing problems that are new or worsening
  • Pregnancy or suspected pregnancy during treatment

Warnings and Precautions

  • Bone marrow suppression: can cause serious infection or bleeding and has been fatal.
  • Severe allergic reactions: may include fever, chills, wheezing and low blood pressure.
  • IV leakage: can cause swelling, pain and tissue damage.
  • Secondary leukemia: reported with etoposide use.
  • Low albumin: may raise the risk of side effects.
  • Pregnancy: can harm a fetus.

Interactions

Some medicines change etoposide levels or are affected by it.

  • Strong CYP3A inhibitors: may raise etoposide levels.
  • Strong CYP3A inducers: may lower etoposide levels and reduce effectiveness.
  • Warfarin: INR can rise, so more frequent monitoring is needed.
  • Cisplatin: linked to reduced etoposide clearance.

Interactions Listed in the FDA-Approved Label

From the Etoposide prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Strong CYP3A inhibitors
    What happensMay increase etoposide exposure, which may increase the risk of adverse reactions.
    What to doAvoid concomitant use.
  • Strong CYP3A inducers
    What happensMay reduce etoposide exposure, which may decrease effectiveness.
    What to doAvoid concomitant use.
  • Vitamin K antagonists (warfarin)
    What happensCo-administration with warfarin can result in elevated INR.
    What to doMonitor INR more frequently and modify the dosage of the vitamin K antagonist as appropriate.
Read the label’s full interactions text

7 DRUG INTERACTIONS CYP3A Inhibitors and CYP3A Inducers: Avoid concomitant use of strong CYP3A inhibitors and strong CYP3A inducers with AVOPEF. Vitamin K Antagonists: Monitor INR more frequently and modify the dosage of the vitamin K antagonists as appropriate. Co-administration of AVOPEF with warfarin can result in elevated international normalized ratio (INR). 7.1 Effect of Other Drugs on AVOPEF CYP3A Inhibitors Avoid concomitant use of strong CYP3A inhibitors. Etoposide is a CYP3A4 substrate. Strong CYP3A inhibitors may increase etoposide exposure, which may increase the risk of AVOPEF-associated adverse reactions. CYP3A Inducers Avoid concomitant use of strong CYP3A inducers. Etoposide is a CYP3A4 substrate. Strong CYP3A inducers may reduce etoposide exposure, which may decrease the effectiveness of AVOPEF. 7.2 Effect of AVOPEF on Other Drugs Vitamin K Antagonists Monitor INR more frequently and modify the dosage of the vitamin K antagonists as appropriate. Co-administration of AVOPEF with warfarin can result in elevated international normalized ratio (INR).

Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use if you have had a severe allergic reaction to etoposide products.
  • Avoid pregnancy and discuss contraception with your doctor.
  • Do not breastfeed during Avopef treatment.
  • Etoposide may affect fertility.
  • Older adults may have more side effects.
  • Kidney impairment may require a lower dose.
  • Children: safety and effectiveness of Avopef have not been established.

Overdose

No antidote has been established for Etopophos overdose in humans. Animal studies suggest overdose may cause neurotoxicity (nerve and brain effects). Seek emergency help if an overdose is suspected.

Half-Life and How Your Body Processes It

After IV dosing, etoposide leaves the blood in two phases, with a final half-life of about 4 to 11 hours. It does not build up with daily dosing over 4 to 5 days. It is highly bound to proteins and enters spinal fluid poorly. The body clears it through the kidneys and through metabolism and bile. The CYP3A4 enzyme is involved in breaking it down. Capsules are absorbed about 50% on average, with wide variation.

Storage

Store at 20°C to 25° C (68°F to 77° F); excursions permitted to 15°C to 30°C (59°F to 86°F). Store the partially used multiple-dose vial in the original carton at controlled room temperature, 20°C to 25°C (68°F to 77°F) for up to 28 days .

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Etoposide

From the licensed clinical database we use, rolled up per supplement, most serious first.

157 supplements and herbal products have documented interactions with Etoposide in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 5Major
  • 110Moderate
  • 42Minor

See the other 149

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Etoposide: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Etoposide — the kind of thing our pharmacy team would talk through with you at the counter.

What is etoposide used for?

It is a chemotherapy medicine used with other cancer drugs. It treats small cell lung cancer, and the injection forms also treat refractory testicular cancer. Your cancer team picks the form that fits your treatment plan.

How do I take etoposide?

The capsules are swallowed and the injection is given into a vein by a healthcare team. It is given in cycles, with breaks in between for recovery. Follow your prescriber's schedule exactly, and keep capsules refrigerated.

What side effects should I expect?

Nausea, vomiting, low appetite, diarrhea, mouth sores, tiredness and hair loss are common. Low blood counts are also common. Hair loss is usually reversible, and nausea can often be controlled with anti-nausea medicine.

When should I call my doctor?

Call right away for fever, chills, signs of infection, unusual bleeding or bruising. Also call for trouble breathing, swelling of the face or tongue, or pain and swelling at the IV site. These can signal serious problems.

Is etoposide safe during pregnancy?

No. Etoposide can harm an unborn baby. Tell your doctor if you are or could become pregnant, and talk about contraception. The Avopef label also advises against breastfeeding during treatment and for 1 week after.

Do I need blood tests while taking etoposide?

Yes. Etoposide can lower your blood counts, so they are checked before each cycle and at other times during and after treatment. Treatment may be held if counts get too low.

Is etoposide available over the counter?

No. Etoposide is a prescription medicine: every etoposide product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was etoposide first available?

The earliest FDA record we hold for etoposide is from 1983: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when etoposide was first used.

Who makes etoposide?

10 companies currently list etoposide products in the FDA's NDC Directory, including BluePoint Laboratories, Hikma Pharmaceuticals USA Inc., Meitheal Pharmaceuticals Inc.. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of etoposide?

Etoposide is the generic name. Its brand names are VePesid, Toposar, Etopophos and Avopef. Generic versions are listed under the name etoposide.

What is the generic name of VePesid?

The generic name of VePesid is etoposide. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is etoposide?

Etoposide belongs to the drug class Topoisomerase Inhibitor, its established pharmacologic class on the FDA label.

Is there a generic version of etoposide?

Yes. FDA-approved generic versions of etoposide are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does etoposide come in?

Etoposide is listed in the FDA's National Drug Code Directory in these forms and strengths. Injection (into a vein): 100 mg, 100 mg/5 mL and 500 mg/25 mL. Capsule (by mouth): 50 mg. A listing does not mean every pharmacy stocks every strength.

How much does etoposide cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, state Medicaid programs paid an average of $75.34 per 50 mg generic capsule over the four quarters through Q1 2026 (CMS's State Drug Utilization Data), before the rebates drug makers pay Medicaid. CMS's weekly pharmacy survey (NADAC) has no price for it, and Medicaid's figure is what a program paid, not the price at the counter. No national price was found for etoposide injections. The pharmacy prices section of this page lists every strength priced.

Is there a etoposide shortage?

No. Etoposide is not on the FDA's drug shortage list as of Nov 22, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the etoposide prescribing information (package insert)?

The full FDA-approved prescribing information for etoposide, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Avyxa Pharma, LLC's, revised Oct 7, 2026, and links to it on DailyMed.

Can you crush etoposide?

Some forms of etoposide are on our Do Not Crush list of tablets and capsules that should not be crushed or chewed: etoposide (capsule); Vepesid (capsule). Crushing or splitting a hazardous drug can expose whoever handles it. A form that is not on the list may still come with its own instructions, so check the label and ask your pharmacist before you crush, split or open any medicine. Each listed form’s reason and instructions are on our Do Not Crush list.

Is etoposide gluten free?

No etoposide label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 19 etoposide products from 10 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's etoposide by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See etoposide inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Etoposide

Skip the scrolling. Ask in your own words and get an answer from Etoposide’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Etoposide’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Etoposide on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Etoposide Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Etoposide Forms and Strengths (How It Comes)

Etoposide comes in 2 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Etoposide inactive ingredients by manufacturer.

Injection

Into a vein
Brands Toposar (1995, discontinued) Etopophos Avopef (2026)
How this form is used
What it may be used for
  • Etoposide Injection is used with other chemotherapy for refractory testicular tumors and first-line small cell lung cancer.
  • Etopophos is used for refractory testicular tumors and, with cisplatin, for first-line small cell lung cancer.
  • Avopef is used with chemotherapy for refractory testicular cancer, and with chemotherapy and immunotherapy for first-line small cell lung cancer in adults.
Important instructions
  • Avopef is diluted and given by IV infusion over 30 to 60 minutes.
  • Etopophos should not be given as a bolus injection.
  • Etoposide Injection is given by slow IV infusion, usually over 30 to 60 minutes.
Available strengths 4 strengths
16 FDA-listed product records ⓘ

Capsule

By mouth
Brands VePesid (the first brand, 1983)
How this form is used
What it may be used for
  • VePesid capsules are used with other chemotherapy as first-line treatment for small cell lung cancer.
  • Etoposide capsules are used with other chemotherapy as first-line treatment for small cell lung cancer.
Important instructions
  • VePesid capsules are stored in the refrigerator.
  • Wear impervious gloves when handling VePesid blister packs.
  • Etoposide capsule courses are repeated every 3 to 4 weeks after recovery from side effects.
Available strengths 1 strength
3 FDA-listed product records ⓘ

Etoposide on the U.S. Market: Products, Makers and Brands

How Etoposide appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

10 companies list 19 Etoposide product records with the FDA, mostly as injection, capsule; the earliest marketing or approval year on record is 1983. Brand names in the directory today include VePesid, Etopophos and Avopef; the rest are generics.

2
Dose forms ⓘ
10
Labelers (makers, repackagers, distributors)
4
Brand names ⓘ
19
FDA-listed product records ⓘ
1983
Earliest FDA record ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (4) · Unfinished capsule (1) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

BluePoint Laboratories21%
Hikma Pharmaceuticals USA Inc.21%
Meitheal Pharmaceuticals Inc.16%
Avyxa Pharma, LLC11%
Accord Healthcare Inc.5%
Amneal Pharmaceuticals NY LLC5%
Other makers21%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Etoposide Is Used (Medicaid Data)

How many Etoposide prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

14,672
Medicaid prescriptions filled (Q1–Q4 2025)
$970,346 paid by Medicaid, before rebates

How commonly is Etoposide prescribed? Of the 1,682 medications we measure, Etoposide ranks #876 by Medicaid prescriptions — more than 48% of them.

Where Etoposide ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Etoposide product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 20 mg/mL injectable solution is the most-dispensed Etoposide product — about 98% of these Medicaid prescriptions.

etoposide 20 MG/ML Injectable Solution Most dispensed

14,326 Medicaid prescriptions (Q1–Q4 2025) 98% of Etoposide prescriptions shown $716,164 paid by Medicaid, before rebates ≈ $50 per prescription, before rebates

15 of 30 listed NDCs had Medicaid claims. RxNorm 310248

etoposide 100 MG Injection

178 Medicaid prescriptions (Q1–Q4 2025) 1% of Etoposide prescriptions shown $10,841 paid by Medicaid, before rebates ≈ $61 per prescription, before rebates

1 of 1 listed NDCs had Medicaid claims. RxNorm 1734340

etoposide 50 MG Oral Capsule

168 Medicaid prescriptions (Q1–Q4 2025) 1% of Etoposide prescriptions shown $243,340 paid by Medicaid, before rebates ≈ $1,448 per prescription, before rebates

1 of 5 listed NDCs had Medicaid claims. RxNorm 197687

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 17 of the 36 listed Etoposide NDCs had Medicaid claims.

Compare Etoposide Products

A representative set of FDA-listed product records for Etoposide — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category ⓘ Details
💊Capsule
50 mg Oral Amneal Pharmaceuticals LLC NDA AUTHORIZED GENERIC View NDC →
50 mg Oral Mylan Pharmaceuticals Inc. ANDA View NDC →
50 mg Oral Onesource Specialty Pharma Limited NDA View NDC →
💊Injection
20 mg/mL Intravenous Accord Healthcare Inc. ANDA View NDC →
100 mg/5 mL Intravenous Avyxa Pharma, LLC NDA View NDC →
500 mg/25 mL Intravenous Avyxa Pharma, LLC NDA View NDC →
20 mg/mL Intravenous BluePoint Laboratories × 4 listings ANDA View NDC →
20 mg/mL Intravenous Fresenius Kabi USA, LLC ANDA View NDC →
100 mg Intravenous H2-Pharma, LLC NDA View NDC →
20 mg/mL Intravenous Hikma Pharmaceuticals USA Inc. × 4 listings ANDA View NDC →
20 mg/mL Intravenous Meitheal Pharmaceuticals Inc. × 3 listings ANDA View NDC →

Showing 19 of 19 products — FDA National Drug Code Directory. See every product, package size and price: browse all 19 Etoposide NDCs →

Etoposide Side Effects Reported to the FDA (FAERS)

After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Etoposide — a signal of what to watch for, not proof the drug caused it.

The effects most often named in FDA reports that mention Etoposide are febrile neutropenia, neutropenia, disease progression; about 97% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.

75,997
Reports mentioning it
97%
Reported as serious
12
Distinct effects shown
Most reported effects
Febrile Neutropenia
7,887
Neutropenia
5,184
Disease Progression
4,719
Thrombocytopenia
4,237
Pyrexia
3,559
Anaemia
3,453
Sepsis
3,103
Death
2,922
Pancytopenia
2,877
Pneumonia
2,567
Age groups
Adult · 7,317Elderly · 3,027Child · 1,983Adolescent · 838Infant · 561Neonate · 241

Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Etoposide in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.

Etoposide FDA Approval History

How Etoposide went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.

Etoposide was first approved by the FDA in 1983 (Brand: VEPESID · Corden Pharma); the first generic version was approved in 1994. It remains available in U.S. pharmacies today.

1983
Brand approved
Brand: VEPESID · Corden Pharma
1994
First generic approved
Lower-cost ANDA competition begins
2026
Available today
Active in U.S. pharmacies

Source: Drugs@FDA.

Etoposide Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Etoposide recalls since July 2021.

✅No Etoposide recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Etoposide in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
3
Strengths
4
Forms in current FDA listings
3 of 3
In current FDA listings No current FDA listing
Ingredient (IN) Etoposide RxCUI 4179
  1. Dose form (SCDF) Injectable Solution RxCUI 376890
    In current FDA listings
    Its strength (SCD)
  2. Dose form (SCDF) Injection RxCUI 1734339
    In current FDA listings
    Its strength (SCD)
  3. Dose form (SCDF) Oral Capsule RxCUI 372132
    In current FDA listings
    Its 2 strengths (SCD)
    • 50 mg RxCUI 197687
    • 100 mg RxCUI 199315

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Medicaid Pays for Etoposide

CMS’s weekly pharmacy survey (NADAC) has no price for Etoposide, so here is what state Medicaid programs paid for it over the four quarters through Q1 2026, before rebates. It is not your price at the counter.

No price was found for Etoposide injections, so the prices below are for the capsules only.

FormStrengthVersion What Medicaid paid
Capsule · Oral 50 mg Generic $75.34 per capsule NDC details & Medicaid use
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS State Drug Utilization Data, total paid divided by units paid for across every state, for each strength’s packages.

Etoposide Brand Names

Etoposide has 4 brand names on record: VePesid, Toposar, Etopophos and Avopef. VePesid, Etopophos and Avopef are in the FDA’s product directory today; Toposar is not. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

VePesid the first brand, 1983 Toposar 1995, discontinued Etopophos Avopef 2026

Who Makes Etoposide: Manufacturers and Labelers

10 companies list Etoposide products with the FDA. By number of product records, the largest are BluePoint Laboratories, Hikma Pharmaceuticals USA Inc., Meitheal Pharmaceuticals Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

BluePoint Laboratories 4 Hikma Pharmaceuticals USA Inc. 4 Meitheal Pharmaceuticals Inc. 3 Avyxa Pharma, LLC 2 Accord Healthcare Inc. 1 Amneal Pharmaceuticals NY LLC 1 Fresenius Kabi USA, LLC 1 H2-Pharma, LLC 1 Mylan Pharmaceuticals Inc. 1 Onesource Specialty Pharma Limited 1

Sources for This Etoposide Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Oct 7, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Etoposide.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 9 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
9
Finished products in the current FDA directory
19
Companies listing them (makers, repackagers, distributors)
10
FDA labeler codes behind them ⓘ
10
Linked representative label ⓘ
Avyxa Pharma, LLC
Linked label effective
Oct 7, 2026
Composite sections available
24
Linked SPL Set ID
acc1e443-ef7b-486f-a638-710a20e81059
Linked SPL Document ID
d2f8949c-2fc5-46c5-befb-f03cbb80d59e
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Avyxa Pharma, LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →